1996
DOI: 10.1007/bf02246407
|View full text |Cite
|
Sign up to set email alerts
|

5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response tod-fenfluramine challenge in physically healthy human subjects

Abstract: Prolactin responses to d-fenfluramine (d-FEN) challenge (0.5 mg/kg PO) were examined after pre-treatment with and without the 5-HT2a/2c receptor antagonist amesergide in eight physically healthy male volunteers. Compared to pretreatment with placebo, pre-treatment with amesergide completely blocked the prolactin (PRL) response to d-FEN challenge in all subjects. These data are consistent with data demonstrating a complete blockade of the PRL response to d-FEN with the 5-HT2a/2c receptor antagonist ritanserin, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
19
0
1

Year Published

1996
1996
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(20 citation statements)
references
References 26 publications
0
19
0
1
Order By: Relevance
“…At least in part, prolactin response to fenfluramine challenge seems to be mediated by post-synaptic 5-HT2A/2C receptors (Coccaro et al 1996a;Goodall et al 1993). Our findings suggest that depression that is responsive to treatment by an SSRI is not distinguishable from treatment resistant depression by a 5-HT2A/ 2C receptor difference in responsivity as measured by fenfluramine challenge, nor is successful treatment marked by an increase in the functioning of these receptors.…”
Section: Relationship Between Clinical Response and Post-treatment Prmentioning
confidence: 63%
See 1 more Smart Citation
“…At least in part, prolactin response to fenfluramine challenge seems to be mediated by post-synaptic 5-HT2A/2C receptors (Coccaro et al 1996a;Goodall et al 1993). Our findings suggest that depression that is responsive to treatment by an SSRI is not distinguishable from treatment resistant depression by a 5-HT2A/ 2C receptor difference in responsivity as measured by fenfluramine challenge, nor is successful treatment marked by an increase in the functioning of these receptors.…”
Section: Relationship Between Clinical Response and Post-treatment Prmentioning
confidence: 63%
“…A number of studies have investigated the mechanism of fenfluramine effect on prolactin with particular interest in post-synaptic 5-HT receptors (Coccaro et al 1996a(Coccaro et al ,b, 1998Goodall et al 1993;. At least in part, prolactin response to fenfluramine challenge seems to be mediated by post-synaptic 5-HT2A/2C receptors (Coccaro et al 1996a;Goodall et al 1993).…”
Section: Relationship Between Clinical Response and Post-treatment Prmentioning
confidence: 99%
“…27 Fenfluramine-induced prolactin release has been shown to be mediated by 5-HT2C receptors. 28 The HT2CR cys23ser polymorphism examined in this study may have functional effects on mCPP binding in vitro. 5 In a study of normal female subjects, Quested et al 29 found a reduced hypophagic response to mCPP in ser23 carriers, but no effect on endocrine or thermic responses.…”
mentioning
confidence: 79%
“…Second, PRL [d-FEN] responses appear to reflect activation of 5-HT-2c, but not 5-HT-1a or 5-HT-3, receptors. PRL [d-FEN] responses can be completely abolished both in rats (Di Renzo et al, 1989) and humans (Goodall et al, 1993) by ritanserin, and in humans by the 5-HT-2a/2c antagonist, amesergide (Coccaro et al, 1996c). Given the absence of effect of 5-HT-1a (pindolol; Park and Cowen, 1995), 5-HT-2a (amperozide;Albinsson et al, 1994), and 5-HT-3 (ondansetron; Coccaro et al, 1996a) antagonists on PRL [d-FEN] responses, it is likely that the PRL [d-FEN] responses are largely due to activation of 5-HT-2c post-synaptic receptors in the limbic hypothalamus with 5-HT that has been newly synthesized.…”
Section: Discussionmentioning
confidence: 99%
“…The same is true for PD subjects with a history of suicidal, but not self-injurious, behavior and for subjects with a diagnosis of IED by research criteria. On the basis of our knowledge of the neuropsychopharmacology of d-FEN, central 5-HT deficits in impulsive aggressive individuals are likely due to abnormalities involving 5-HT-2c post-synaptic receptors in the limbic hypothalamus (Coccaro et al, 1996c). These data also suggest that the word impulsive, in the term impulsive aggression, describes the form of aggression (ie, as impulsive in nature) associated with central 5-HT deficits demonstrated by a reduction in DPRL[d-FEN]-R responses and not impulsivity in general.…”
Section: Discussionmentioning
confidence: 99%